Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk-a meta-analysis

International Journal of Medical Sciences

Volumn 7, Issue 5, 2010, Pages 300-308

  Zhao, Yaping ^a   Wang, Furu ^b,c   Shan, Shunlin ^a   Zhao, Yiqi ^a   Qiu, Xueming ^a   Li, Xiangyang ^a   Jiao, Feng ^a   Wang, Jian Guo ^a   Du, Yunxiang ^a  

^a The 82th Hospital of the People's Liberation Army   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Esophageal cancer; GSTP1; Meta analysis; p53; Polymorphism

Indexed keywords

ARGININE; GLUTATHIONE TRANSFERASE P1; ISOLEUCINE; PROLINE; PROTEIN P53;

ARTICLE; CANCER RISK; ESOPHAGUS CANCER; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; METHODOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77956956029     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.7.300     Document Type: Article

References (48)

1. Xing D, Tan W, Lin D: Genetic polymorphisms and susceptibility to esophageal cancer among chinese population (review). Oncol Rep 2003;10:1615-1623.
2. Franceschi S, Bidoli E, Negri E, Zambon P, Talamini R, Ruol A, Parpinel M, Levi F, Simonato L, La Vecchia C: Role of macro-nutrients, vitamins and minerals in the aetiology of squam-ous-cell carcinoma of the oesophagus. Int J Cancer 2000;86:626-631.
3. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, Fraumeni JFJr: Risk factors for esophageal cancer in shanghai, china. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192-196.
4. Wu Y, Chen J, Ohshima H, Pignatelli B, Boreham J, Li J, Campbell TC, Peto R, Bartsch H: Geographic association between urinary excretion of n-nitroso compounds and oeso-phageal cancer mortality in china. Int J Cancer 1993;54:713-719.
5. Hu J, Nyren O, Wolk A, Bergstrom R, Yuen J, Adami HO, Guo L, Li H, Huang G, Xu X, et al.: Risk factors for oesophageal cancer in northeast china. Int J Cancer 1994;57:38-46.
6. Hollstein M, Sidransky D, Vogelstein B, Harris CC: P53 mutations in human cancers. Science 1991;253:49-53.
7. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP, et al.: P53 mutation and protein accumulation during multistage human eso-phageal carcinogenesis. Cancer Res 1992;52:6092-6097.
8. Soussi T, Beroud C: Assessing tp53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-240.
9. Peters WH, Roelofs HM, Hectors MP, Nagengast FM, Jansen JB: Glutathione and glutathione s-transferases in barrett's epithelium. Br J Cancer 1993;67:1413-1417.
10. Cobbe SC, Scobie GC, Pohler E, Hayes JD, Kernohan NM, Dillon JF: Alteration of glutathione s-transferase levels in barrett's metaplasia compared to normal oesophageal epithelium. Eur J Gastroenterol Hepatol 2003;15:41-47.
11. Chandra RK, Bentz BG, Haines GK3rd, Robinson AM, Radose-vich JA: Expression of glutathione s-transferase pi in benign mucosa, barrett's metaplasia, and adenocarcinoma of the esophagus. Head Neck 2002;24:575-581.
12. Compton KR, Orringer MB, Beer DG: Induction of glutathione s-transferase-pi in barrett's metaplasia and barrett's adenocar-cinoma cell lines. Mol Carcinog 1999;24:128-136.
13. van Lieshout EM, Tiemessen DM, Witteman BJ, Jansen JB, Peters WH: Low glutathione and glutathione s-transferase levels in barrett's esophagus as compared to normal esophageal epithelium. Jpn J Cancer Res 1999;90:81-85.
14. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987;7:961-963.
15. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matla-shewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-1100.
16. Koushik A, Platt RW, Franco EL: P53 codon 72 polymorphism and cervical neoplasia: A meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004;13:11-22.
17. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q: P53 codon 72 polymorphism and risk of gastric cancer in a chinese population. Oncol Rep 2004;11:1115-1120.
18. Lacerda LL, Serrano SV, Mathes A, Rey JA, Bello MJ, Casartelli C: An intronic variant in the tp53 gene in a brazilian woman with breast cancer. Cancer Genet Cytogenet 2005;160:160-163.
19. Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, La-giou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Ri-chiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holcatova I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, Agudo A, Castellsague X, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Brennan P: Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 european countries: The arcage project. Cancer Res 2009;69:2956-2965.
20. Casson AG, Zheng Z, Porter GA, Guernsey DL: Genetic polymorphisms of microsomal epoxide hydroxylase and gluta-thione s-transferases m1, t1 and p1, interactions with smoking, and risk for esophageal (barrett) adenocarcinoma. Cancer Detect Prev 2006;30:423-431.
21. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J: Associations between genetic polymorphisms of phase i and ii metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003;27:139-146.
22. Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, Luh SP, Chen CJ, Hsieh CY, Wu MT: Genetic polymorphisms of p53 and gstp1,but not nat2,are associated with susceptibility to squam-ous-cell carcinoma of the esophagus. Int J Cancer 2000;89:458-464.
23. Vos M, Adams CH, Victor TC, van Helden PD: Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the tp53 gene in a population at high risk for esophageal cancer in south africa. Cancer Genet Cytogenet 2003;140:23-30.
24. Hong Y, Miao X, Zhang X, Ding F, Luo A, Guo Y, Tan W, Liu Z, Lin D: The role of p53 and mdm2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 2005;65:9582-9587.
25. Cai L, Mu LN, Lu H, Lu QY, You NC, Yu SZ, Le AD, Zhao J, Zhou XF, Marshall J, Heber D, Zhang ZF: Dietary selenium intake and genetic polymorphisms of the gstp1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:294-300.
26. Yang W, Zhang Y, Tian X, Ning T, Ke Y: P53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 2008;47:100-104.
27. Liu G, Cescon DW, Zhai R, Zhou W, Kulke MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, Wain JC, Lynch TJ, Christiani DC: P53 arg72pro, mdm2 t309g and ccnd1 g870a polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus. 2010;23(1):36-9
28. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF: Susceptibility to esophageal cancer and genetic polymorphisms in glutathione s-transferases t1, p1, and m1 and cytochrome p450 2e1. Cancer Epidemiol Biomarkers Prev 1998;7:1013-1018.
29. Morita S, Yano M, Tsujinaka T, Ogawa A, Taniguchi M, Kaneko K, Shiozaki H, Doki Y, Inoue M, Monden M: Association between genetic polymorphisms of glutathione s-transferase p1 and n-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 1998;79:517-520.
30. van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB, Peters WH: Polymorphic expression of the gluta-thione s-transferase p1 gene and its susceptibility to barrett's esophagus and esophageal carcinoma. Cancer Res 1999;59:586-589.
31. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX: Impact of genetic polymorphisms in cytochrome p450 2e1 and glutathione s-transferases m1, t1, and p1 on susceptibility to esophageal cancer among high-risk individuals in china. Cancer Epidemiol Biomarkers Prev 2000;9:551-556.
32. Roth MJ, Abnet CC, Johnson LL, Mark SD, Dong ZW, Taylor PR, Dawsey SM, Qiao YL: Polymorphic variation of cyp1a1 is associated with the risk of gastric cardia cancer: A prospective case-cohort study of cytochrome p-450 1a1 and gst enzymes. Cancer Causes Control 2004;15:1077-1083.
33. Murphy SJ, Hughes AE, Patterson CC, Anderson LA, Watson RG, Johnston BT, Comber H, McGuigan J, Reynolds JV, Murray LJ: A population-based association study of snps of gstp1, mnsod, gpx2 and barrett's esophagus and esophageal adeno-carcinoma. Carcinogenesis 2007;28:1323-1328.
34. Egger M, Davey Smith G, Schneider M, Minder C: Bias in me-ta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
35. Lee JM, Wu MT, Lee YC, Yang SY, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee CJ, Chen CJ: Association of gstp1 polymorphism and survival for esophageal cancer. Clin Cancer Res 2005;11:4749-4753.
36. Berhane K, Widersten M, Engstrom A, Kozarich JW, Mannervik B: Detoxication of base propenals and other alpha, be-ta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci U S A 1994;91:1480-1484.
37. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernstrom B: Differences in the catalytic efficiencies of allelic variants of glutathione transferase p1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998;19:433-436.
38. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S, Awasthi YC: Naturally occurring human glutathione s-transferase gstp1-1 isoforms with isoleu-cine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893-899.
39. Hu X, Xia H, Srivastava SK, Herzog C, Awasthi YC, Ji X, Zim-niak P, Singh SV: Activity of four allelic forms of glutathione s-transferase hgstp1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997;238:397-402.
40. Hiyama T, Yoshihara M, Tanaka S, Chayama K: Genetic polymorphisms and esophageal cancer risk. Int J Cancer 2007;121:1643-1658.
41. Velculescu VE, Zhang L, Zhou W, Vogelstein J, Basrai MA, Bassett DEJr., Hieter P, Vogelstein B, Kinzler KW: Characterization of the yeast transcriptome. Cell 1997;88:243-251.
42. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJr., Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-221.
43. Malkin D, Li FP, Strong LC, Fraumeni JFJr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al.: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238.
44. Zhang L, Xing D, He Z, Lin D: [p53 gene codon 72 polymorphism and susceptibility to esophageal squamous cell carcinoma in a chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:10-13.
45. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JFJr.: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-1413.
46. DeMarini DM: Genotoxicity of tobacco smoke and tobacco smoke condensate: A review. Mutat Res 2004;567:447-474.
47. Malats N, Camus-Radon AM, Nyberg F, Ahrens W, Constan-tinescu V, Mukeria A, Benhamou S, Batura-Gabryel H, Bruske-Hohlfeld I, Simonato L, Menezes A, Lea S, Lang M, Boffetta P: Lung cancer risk in nonsmokers and gstm1 and gstt1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2000;9:827-833.
48. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Naka-jima M, Fukai Y, Sohda M, Kimura H, Faried A: Genetic alterations in esophageal cancer. Surg Today 2005;35:7-18.